# Seegene Inc.

Seegene Inc. is an other based in Seongnam, South Korea.

## Overview

- **Organization type:** other
- **Headquarters:** Seongnam, South Korea
- **Region:** Asia
- **Address:** Seongnam, South Korea
- **Assets under management:** Undisclosed
- **Website:** seegene.co.kr
- **LinkedIn:** https://www.linkedin.com/company/seegene-inc

## Regulatory record

- **Reports private funds:** No

## Sectors

- Healthcare Services

## Offices

- Seoul
- Hwaseong
- Foster City

## Questions

### What technology does Seegene use for diagnostics?

Seegene’s core technology is syndromic real-time PCR, which can detect multiple pathogens — such as respiratory viruses, gastrointestinal bacteria, and sexually transmitted infections — in a single test. The firm integrates AI-driven reagent design, modular automation systems, and a global data surveillance platform. This approach enables rapid, scalable testing across diverse clinical settings.

### What is Seegene’s Technology-Sharing Initiative?

Launched by the firm, the Technology-Sharing Initiative licenses Seegene’s proprietary molecular diagnostic technology to global partners and researchers. This program aims to accelerate development of syndromic tests for various diseases in different regions. It reflects Seegene’s strategy to expand its technology footprint beyond direct product sales through collaborative co-development.

### How does Seegene source innovation for its product pipeline?

Seegene develops its own reagents and systems internally, supported by over 900 employees in R&D, manufacturing, and sales. It also engages in partnerships with global healthcare organizations and academic researchers via its Technology-Sharing Initiative. The firm’s platform combines AI-driven reagent design with real-world diagnostic data from its surveillance network to guide new test development.

### What investment stages does Seegene typically target?

Seegene is not an investment firm and does not target financial investment stages. Its activities are operational — focusing on product development, commercialization, and technology licensing. Capital allocation decisions involve R&D spending, manufacturing capacity, and global distribution expansion rather than portfolio investments.

## Related profiles

- [Candid Ventures](https://altss.com/profile/candid-ventures)
- [ONC Capital](https://altss.com/profile/onc-capital)

---

Last updated: 2026-05-31T00:04:40.478Z

Canonical page: https://altss.com/profile/seegene-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology